Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Treatment of Heart Failure: a Non-interventional Observational Study of Patients With Heart Failure and Initiated on Dapagliflozin in Portugal

NCT05465213 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05465213
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05465213 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Treatment of Heart Failure: a Non-interventional Observational Study of Patients With Heart Failure and Initiated on Dapagliflozin in Portugal
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 28, 2022
Completion date
June 24, 2024
Enrollment
283 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure